Is ROOT Stock the Next Big Thing?
Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…
Sell
32
JAZZ Quote, Financials, Valuation and Earnings
Last price:
$110.05
Seasonality move
:
17.35%
Day range:
$109.76 - $117.12
52-week range:
$99.06 - $148.06
Dividend yield:
0%
P/E ratio:
12.52x
P/S ratio:
1.74x
P/B ratio:
1.63x
Volume:
2.2M
Avg. volume:
1.3M
1-year change:
-4.49%
Market cap:
$6.7B
Revenue:
$4.1B
EPS (TTM):
$8.79
Earnings Data
Next earnings date for JAZZ
May 01
2025
Most recent earnings per share
$3.11
Missed by $2.70
(Feb 25/2025)
Consensus Estimate
$5.81
(Feb 25/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
JAZZ Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $1.1B | -- | -- | $5.78 | -- |
| 05/01/2025 | Q1 | $984.2M | -- | -- | $4.78 | -- |
| 02/25/2025 | Q4 | $1.1B | $1.1B | $3.11 | $5.81 | -$2.70 |
| 11/06/2024 | Q3 | $1B | $1.1B | $3.42 | $5.50 | -$2.08 |
| 07/31/2024 | Q2 | $1B | $1B | $2.49 | $4.78 | -$2.29 |
| 05/01/2024 | Q1 | $954.3M | $902M | -$0.23 | $4.18 | -$4.41 |
| 02/28/2024 | Q4 | $1B | $1B | $1.42 | $5.18 | -$3.76 |
| 11/08/2023 | Q3 | -- | -- | $2.14 | $4.93 | -$2.79 |
| 08/09/2023 | Q2 | -- | -- | $1.52 | $4.43 | -$2.91 |
| 05/10/2023 | Q1 | -- | -- | $1.04 | $4.22 | -$3.18 |
| 03/01/2023 | Q4 | -- | -- | -$3.82 | $1.12 | -$4.94 |
| 11/09/2022 | Q3 | -- | -- | -$0.31 | $4.67 | -$4.98 |
| 08/03/2022 | Q2 | -- | -- | $0.55 | $4.19 | -$3.64 |
| 05/04/2022 | Q1 | -- | -- | $0.03 | $3.89 | -$3.86 |
| 03/01/2022 | Q4 | -- | -- | -$0.57 | $3.64 | -$4.21 |
| 11/09/2021 | Q3 | -- | -- | -$0.86 | $3.31 | -$4.17 |
| 08/03/2021 | Q2 | -- | -- | -$6.11 | $3.45 | -$9.56 |
| 05/04/2021 | Q1 | -- | -- | $2.09 | $3.73 | -$1.64 |
| 02/23/2021 | Q4 | -- | -- | $2.33 | $4.20 | -$1.87 |
| 11/02/2020 | Q3 | -- | -- | $2.64 | $4.08 | -$1.44 |
| 08/04/2020 | Q2 | -- | -- | $2.06 | $3.11 | -$1.05 |
| 05/05/2020 | Q1 | -- | -- | -$2.82 | $0.67 | -$3.49 |
| 02/25/2020 | Q4 | -- | -- | $1.29 | $4.12 | -$2.83 |
| 11/05/2019 | Q3 | -- | -- | $1.78 | $3.59 | -$1.81 |
| 08/06/2019 | Q2 | -- | -- | $4.05 | $3.57 | $0.48 |
| 05/07/2019 | Q1 | -- | -- | $3.67 | $3.16 | $0.51 |
| 02/26/2019 | Q4 | -- | -- | $3.64 | $3.03 | $0.61 |
| 11/06/2018 | Q3 | -- | -- | $3.58 | $3.32 | $0.26 |
| 08/07/2018 | Q2 | -- | -- | $3.49 | $3.21 | $0.28 |
| 05/08/2018 | Q1 | -- | -- | $2.98 | $2.78 | $0.20 |
| 02/27/2018 | Q4 | -- | -- | $2.95 | $2.96 | -$0.01 |
| 11/07/2017 | Q3 | -- | -- | $3.22 | $2.89 | $0.33 |
| 08/08/2017 | Q2 | -- | -- | $2.56 | $2.75 | -$0.19 |
| 05/09/2017 | Q1 | -- | -- | $2.31 | $2.34 | -$0.03 |
| 02/28/2017 | Q4 | -- | -- | $1.91 | $1.65 | $0.26 |
| 11/08/2016 | Q3 | -- | -- | $2.16 | $1.57 | $0.59 |
| 08/09/2016 | Q2 | -- | -- | $1.80 | $1.71 | $0.09 |
| 05/10/2016 | Q1 | -- | -- | $1.87 | $1.31 | $0.56 |
| 02/23/2016 | Q4 | -- | -- | $2.27 | $1.66 | $0.61 |
| 11/09/2015 | Q3 | -- | -- | $1.39 | $1.49 | -$0.10 |
| 08/05/2015 | Q2 | -- | -- | $2.11 | $2.16 | -$0.05 |
Jazz Pharmaceuticals PLC Earnings Questions
-
How Much did Jazz Pharmaceuticals PLC Generate in Revenue Last Quarter?
Jazz Pharmaceuticals PLC reported $1.1B worth of top line sales in its most recent quarter.
-
Did Jazz Pharmaceuticals PLC Beat Earnings Last Quarter?
Jazz Pharmaceuticals PLC announced earnings per share of $3.11 which represents a miss of analyst forecast a $5.81 per share.
-
Is Jazz Pharmaceuticals PLC Profitable?
Jazz Pharmaceuticals PLC reported $959.5M that represents $15.60 per share over the last quarter.
-
What is the Analyst Consensus for Jazz Pharmaceuticals PLC EPS Next Year?
Jazz Pharmaceuticals PLC's earnings are forecast to grow from $8.65 per share to $23.31 per share next year representing an increase of 171%.
-
When is Jazz Pharmaceuticals PLC's Earnings Date?
Jazz Pharmaceuticals PLC's next earnings date is May 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta a Good Stock to Buy?
Okta (NASDAQ:OKTA) is used by some of the largest firms…
Is Fidelity High Dividend ETF a Good Investment Now?
Fidelity’s High Dividend ETF (FDVV) is a fund that offers…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 5
Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.
Sell
25
GDXU alert for Apr 5
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.
Buy
76
SOXS alert for Apr 5
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.
